🇺🇸 FDA
Patent

US 6290981

Use of nitric oxide-releasing agents to treat impotency

expired A61KA61K31/655A61K31/785

Quick answer

US patent 6290981 (Use of nitric oxide-releasing agents to treat impotency) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/655, A61K31/785, A61K47/58, A61K47/59